IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Bharat Majeti

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 6.6

ph-index = 3

Forward Citations = 26(Granted Patents)


Company Filing History:

goldMedal12 out of 3,868 
 
Nitto-denko Corporation
 patents

Years Active: 2017-2025

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 12440445 - Fusogenic compounds for delivery of biologically active molecules (2025-10-14),
2. 12319643 - Ionizable compounds and compositions and uses thereof (2025-06-03),
3. 11708575 - RNA interference delivery formulation and methods for malignant tumors (2023-07-25),
4. RE49229 - Methods and compositions for treating malignant tumors associated with KRAS mutation (2022-10-03),
5. 11413243 - Fusogenic compounds for delivery of biologically active molecules (2022-08-16),
6. 11384051 - Ionizable compounds and compositions and uses thereof (2022-07-12),
7. 11352628 - Methods and compositions for treating malignant tumors associated with KRAS mutation (2022-06-07),
8. RE48887 - RNA interference compositions and methods for malignant tumors (2022-01-10),
9. 10792299 - Methods and compositions for treating malignant tumors associated with kras mutation (2020-10-06),
10. 10167253 - Ionizable compounds and compositions and uses thereof (2019-01-01),
11. 9771582 - RNA interference compositions and methods for malignant tumors (2017-09-26),
12. 9580710 - Methods and compositions for treating malignant tumors associated with KRAS mutation (2017-02-28),

Title: Bharat Majeti: Innovator in Biopharmaceuticals

Introduction

Bharat Majeti is a prominent inventor based in San Diego, California, known for his significant contributions to the field of biopharmaceuticals. With a total of 12 patents to his name, he has made remarkable advancements in the delivery of biologically active molecules.

Latest Patents

Among his latest patents are "Fusogenic compounds for delivery of biologically active molecules" and "Ionizable compounds and compositions and uses thereof." The fusogenic compounds are designed to create nanoparticle compositions that can be utilized in biopharmaceuticals and therapeutics. These compounds aim to encapsulate active agents, facilitating their delivery to cells, tissues, organs, and subjects. Similarly, the ionizable compounds serve a comparable purpose, focusing on the encapsulation of nucleic acid agents for effective distribution.

Career Highlights

Bharat Majeti is currently associated with Nitto Denko Corporation, where he continues to innovate and develop new technologies in the biopharmaceutical sector. His work has been instrumental in enhancing the efficacy of drug delivery systems.

Collaborations

He collaborates with notable colleagues such as Wenbin Ying and Roger C Adami, contributing to a dynamic research environment that fosters innovation.

Conclusion

Bharat Majeti's work in the field of biopharmaceuticals exemplifies the impact of innovative thinking on healthcare solutions. His patents reflect a commitment to advancing drug delivery technologies, ultimately benefiting patients and the medical community.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…